C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
11/2002
11/20/2002	EP1257549A2 Matrix metalloproteinase inhibitors and uses thereof
11/20/2002	EP1257536A1 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/20/2002	EP1257535A1 Substituted pyridine compounds useful for controlling chemical synaptic transmission
11/20/2002	EP1257265A2 Use of 2-phenylene diamine derivatives for the treatment of infections
11/20/2002	EP1257262A2 Pharmacological agent comprising picolinic acid, fusaric acid and derivatives thereof
11/20/2002	EP0892780B1 M-AMIDINO PHENYL ANALOGS AS FACTOR Xa INHIBITORS
11/20/2002	CN1380880A Process for producing substituted aromatic compound
11/19/2002	US6482962 Contacting helminth, nematode, insect or acarid pests or parasites or their food supply, habitat or breeding grounds with a nitroethyl derivative
11/19/2002	US6482955 Organometallic reagent reacted with an activated carboxylic acid to produce a ketone reacted with carbon disulfide and dihalomethane, further reacting the dithietane product with a secondary amine, and condensing the thioamide with hydrazine
11/19/2002	US6482951 Isoindolin-1-one glucokinase activators
11/19/2002	US6482947 Substituted (hetero) aryl compounds, process for their preparation, agents containing them and their use as safeners
11/19/2002	US6482860 Pentafluorobenzenesulfonamides and analogs
11/19/2002	US6482859 Microbicidal N-sulfonylglycin alkynyloxyphenethyl amide derivatives
11/19/2002	US6482849 Inhibitors of α4β1 mediated cell adhesion
11/19/2002	US6482841 Pyridyl compounds and pharmaceutical compositions containing them
11/19/2002	US6482827 Matrix metalloproteinase inhibitors
11/19/2002	US6482814 Biocidal composition and its use
11/19/2002	CA2225780C New derivatives of n-benzylpiperazine, their preparation process and the pharmaceutical compositions they contain
11/14/2002	WO2002090442A1 Pyridone dyes, a process for their preparation and their use in the production of coloured plastics or polymeric colour particles
11/14/2002	WO2002090352A2 Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3
11/14/2002	WO2002090349A1 N-oxide anthranylamide derivatives and their use as medicaments
11/14/2002	WO2002090347A1 Amide compounds
11/14/2002	WO2002090333A1 Novel pyridinone and related heterocyclic derivatives
11/14/2002	WO2002090332A2 Novel aeylheteroalkylaminε derivatives
11/14/2002	WO2002090331A1 Method for producing 1,3-disubstituted 2-nitroguanidines
11/14/2002	WO2002090330A1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
11/14/2002	WO2002090329A1 Cationic amphiphiles as transfection vehicles
11/14/2002	WO2002090328A1 The preparation of substituted pyridines utilizing nitric and an anhydride
11/14/2002	WO2002090325A2 Benzazepinone alpha v integrin receptor antagonists
11/14/2002	WO2002090317A1 Substituted cyclohexane-1,4-diamine derivatives
11/14/2002	WO2002090314A1 Pyruvate derivatives
11/14/2002	WO2002089798A2 Method and compositions for treating migraines
11/14/2002	WO2002089783A1 Substituted cyclohexan-1,4-diamine derivatives with constipating and peripheral analgesic properties
11/14/2002	WO2002089745A2 Substituted n'-(arylcarbonyl)-benzhydrazides, n'-(arylcarbonyl)-benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/14/2002	WO2002089738A2 Proteomimetic compounds and methods
11/14/2002	WO2002068417A3 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
11/14/2002	WO2002038534A3 Substituted alkyldiamines as inhibitors of plasmepsin or related proteases
11/14/2002	WO2002024650B1 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
11/14/2002	US20020169336 Able to inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders
11/14/2002	US20020169318 Novel thrombin inhibitors
11/14/2002	US20020169206 Substituted biphenyl compounds for the treatment of inflammation
11/14/2002	US20020169203 Modulators of all three classes of calcium channel blocker subtypes (Small, Intermediate and Big conductance K channel (SK, IK and BK)) comprising malonate esters and nitriles; respiratory, brain, cardiovascular, urogenital disorders
11/14/2002	US20020169200 Antitumor, antiinflammatory and antiarthritic agents, treating metastasis, restenosis, osteoporosis, inflammation, macular degeneration, and diabetic retinopathy
11/14/2002	US20020169189 Benzamide derivatives as thrombin inhibitors
11/14/2002	US20020169185 Quinolinyl and benzothiazolyl modulators
11/14/2002	US20020169170 Arylpiperazines having activity at the serotonin 1A receptor
11/14/2002	US20020169161 Bicyclic sulfanimde compounds useful for the treatment of cardiac arrhythmias
11/14/2002	US20020169159 An acetamide derivative is useful for treatment of inflammatory and immune conditions and diseases; modulates the expressin and/or function of a chemokine receptor
11/14/2002	DE10122025A1 Verfahren zur Herstellung von Terpyridinen A process for preparing terpyridines
11/14/2002	CA2453223A1 Selective anthranilamide pyridinamides as vegfr-2 and vegfr-3 inhibitors
11/14/2002	CA2446735A1 Substituted cyclohexane-1,4-diamine derivatives with an anti-diarrhoea and peripheral analgesic action
11/14/2002	CA2446380A1 Proteomimetic compounds and methods
11/14/2002	CA2446120A1 Novel arylheteroalkylamine derivatives
11/14/2002	CA2445679A1 Benzazepinone alpha v integrin receptor antagonists
11/14/2002	CA2445502A1 Method and compositions for treating migraines
11/14/2002	CA2445022A1 Pyridone dyes, a process for their preparation and their use in the production of coloured plastics or polymeric colour particles
11/13/2002	EP1256580A1 Process for the preparation of terpyridyls
11/13/2002	EP1256576A1 Fused imidazolium derivatives
11/13/2002	EP1256574A1 Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same
11/13/2002	EP1256569A1 Phenacylamine derivatives, production thereof and pest controllers containing the derivatives
11/13/2002	EP1256342A1 Hypoglycemics comprising organic zinc (ii) complexes
11/13/2002	EP1255757A1 Amino acid derivatives and use thereof as nep, ace and ece inhibitors
11/13/2002	EP1255735A2 Pyridine derivatives as potentiators of glutamate receptors
11/13/2002	EP1255726A2 (r)-2-aryl-propionamides, useful in the inhibition of il-8 induced chemiotaxis of neutrophils
11/13/2002	EP0949921B1 Thrombin inhibitors
11/13/2002	EP0920413B1 Boronic compound complexing reagents and complexes
11/13/2002	EP0760658B1 Compounds for inhibiting osteoclast-mediated bone resorption
11/13/2002	CN1379777A Amino-triazolopyridine derivatives
11/13/2002	CN1379762A Beta substituted metalloprotease inhibitors
11/13/2002	CN1379669A Valdecoxib compositions
11/12/2002	US6479666 Phenyl-keto-imidazolidine thioamide derivatives
11/12/2002	US6479664 Process for the preparation of 2-chloro-5-methylpyridine-3-carbaldehyde
11/12/2002	US6479554 Immunotherapeutic agents
11/12/2002	US6479553 Use of certain affinity NMDA antagonists as antidepressants
11/12/2002	US6479552 Use of substituted N, N-disubstituted diamino compounds for inhibiting cholesteryl ester transfer protein activity
11/12/2002	US6479550 α-sulfenimino acid derivatives
11/12/2002	US6479525 Aspartate derivative of amlodipine
11/12/2002	US6479524 To prolong the thrombin time
11/12/2002	US6479519 Inhibitors of cell adhesion; treatment of asthma or inflammatory bowel disease
11/12/2002	US6479507 Modulation of these inflammatory cytokines is considered one of the most effective strategies to block chronic inflammation and have positive therapeutic outcomes
11/12/2002	US6479495 Simultaneously treating depression and memory dysfunction in mammals suffering from memory dysfunction and depression
11/12/2002	US6479492 Compounds which inhibit leukocyte adhesion mediated by VLA-4
11/12/2002	US6479485 Benzamidine derivatives and their use as anti-coagulants
11/12/2002	US6479484 Substituted 2-aminoacetamides and the discovery that these compounds act as blockers of sodium channels; pain relievers, treatment of arrythmia, local anesthetics
11/12/2002	US6479483 3,4,6-substituted pyridine derivatives useful for treating depression and pain, resulting from inflammatory conditions, such as migraine, rheumatoid arthritis, asthma and inflamatory bowel disease; nk1 receptor antagonist
11/12/2002	CA2324959C Phthalimido compounds as intermediates for producing substance p receptor antagonists
11/12/2002	CA2169718C The primary and secondary neuroprotective effect of flupirtine in neurodegenerative diseases
11/07/2002	WO2002088323A2 Gene delivery compounds
11/07/2002	WO2002088289A2 Use of metal complex compounds as oxidation catalysts
11/07/2002	WO2002088114A2 Heteroaryl ofefinic azacyclic and heteroaryl acetylenic azacyclic compounds for the treatment of cns disorders
11/07/2002	WO2002088101A2 Inhibitors of bace
11/07/2002	WO2002088094A1 2-iminoimidazole derivatives (1)
11/07/2002	WO2002088092A1 2-iminoimidazole derivative (2)
11/07/2002	WO2002088084A1 Heterocyclic compound derivatives and medicines
11/07/2002	WO2002088074A1 Phthalamide derivatives, insecticides for agricultural and horticultural use and method for application thereof
11/07/2002	WO2002088073A1 Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof
11/07/2002	WO2002088071A1 20-hydroxyeicosatetraenoic acid production inhibitors
11/07/2002	WO2002087577A1 Medicines
11/07/2002	WO2002087555A2 Use of bisphosphonates in the treatment of bone metastasis associated with prostate cancer
11/07/2002	WO2002087338A1 Liquid formulations for dermal application in treatment of parasitic insects in animals

1 ... 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 ... 633